Muneeza Mirza, MD
Pediatrics · San Jose
- Medicare standing
- 1 flag on the record
- Listed below.
- Plans that list them
- 1
- 1 carrier
- Office
- 1
On the public record
- Medicare does not list them as allowed to order and refer
Offices
1 location
Plans that list them
1 plan · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Mirza’s office at (408) 947-2929 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
California Medical Board record
Licence C53344 · Current
Licensed to practise in California · since 2008 · expires 2027-12-31 · Aga Khan University, Aga Khan Medical College.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Medicaid work
$252,107 in 2024
Medicaid paid $252,107 for 3,753 billed services this clinician did in 2024, up to 137 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Clinic visit/encounter, all-inclusive | 1,181 | $246,360 |
| Influenza virus vaccine, trivalent (IIV3), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 120 | $913 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; early childhood (age 1 through 4 years) | 107 | $866 |
| Short return visit (20+ min) | 1,310 | $847 |
| Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, single dose | 20 | $680 |
| Infectious agent antigen detection by immunoassay with direct optical (ie, visual) observation; severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) | 82 | $610 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; late childhood (age 5 through 11 years) | 151 | $580 |
| Pure tone audiometry (threshold); air only | 120 | $423 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; adolescent (age 12 through 17 years) | 61 | $363 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 39 | $327 |
| Human Papillomavirus vaccine types 6, 11, 16, 18, 31, 33, 45, 52, 58, nonavalent (9vHPV), 2 or 3 dose schedule, for intramuscular use | 14 | $109 |
| Screening performed and negative | 155 | $29 |
| 2024 | 3,753 | 14 | 137 | $252,107 |
| 2023 | 5,792 | 21 | 129 | $276,171 |
| 2022 | 4,830 | 19 | 142 | $220,038 |
| 2021 | 4,716 | 13 | 156 | $284,017 |
| 2020 | 4,994 | 19 | 179 | $298,596 |
| 2019 | 4,538 | 21 | 165 | $241,822 |
| 2018 | 3,378 | 12 | 168 | $192,392 |
See the largest Medicaid services in earlier years
2023
| Clinic visit/encounter, all-inclusive | 1,269 | $253,068 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; early childhood (age 1 through 4 years) | 262 | $4,287 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; late childhood (age 5 through 11 years) | 199 | $3,867 |
| Pure tone audiometry (threshold); air only | 393 | $3,426 |
| Infectious agent antigen detection by immunoassay with direct optical (ie, visual) observation; severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) | 290 | $2,510 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 421 | $2,490 |
| Screening performed and negative | 591 | $2,292 |
| Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, single dose | 47 | $1,480 |
| Developmental screening | 30 | $840 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; adolescent (age 12 through 17 years) | 21 | $605 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); each additional vaccine (single or combination vaccine/toxoid) (List separately in addition to code for primary procedure) | 114 | $260 |
| Pneumococcal conjugate vaccine, 13 valent (PCV13), for intramuscular use | 54 | $258 |
2022
| Clinic visit/encounter, all-inclusive | 1,037 | $202,317 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; early childhood (age 1 through 4 years) | 232 | $4,311 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; late childhood (age 5 through 11 years) | 182 | $3,994 |
| Pure tone audiometry (threshold); air only | 465 | $3,539 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 356 | $2,044 |
| Screening performed and negative | 656 | $1,218 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; infant (age younger than 1 year) | 59 | $935 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; adolescent (age 12 through 17 years) | 29 | $651 |
| Pneumococcal conjugate vaccine, 13 valent (PCV13), for intramuscular use | 55 | $238 |
| Short return visit | 688 | $149 |
| Short return visit (20+ min) | 611 | $129 |
| Diphtheria, tetanus toxoids, acellular pertussis vaccine, inactivated poliovirus vaccine, Haemophilus influenzae type b PRP-OMP conjugate vaccine, and hepatitis B vaccine (DTaP-IPV-Hib-HepB), for intramuscular use | 21 | $105 |
2021
| Clinic visit/encounter, all-inclusive | 1,401 | $273,134 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; late childhood (age 5 through 11 years) | 218 | $3,771 |
| Pure tone audiometry (threshold); air only | 498 | $2,938 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; early childhood (age 1 through 4 years) | 183 | $2,473 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 234 | $868 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; adolescent (age 12 through 17 years) | 31 | $423 |
| Hepatitis A vaccine (HepA), pediatric/adolescent dosage-2 dose schedule, for intramuscular use | 44 | $129 |
| Short return visit (20+ min) | 466 | $79 |
| Human Papillomavirus vaccine types 6, 11, 16, 18, 31, 33, 45, 52, 58, nonavalent (9vHPV), 2 or 3 dose schedule, for intramuscular use | 16 | $79 |
| Short return visit | 1,101 | $60 |
| Screening performed and negative | 189 | $58 |
| HEMOGLOBIN | 20 | $4 |
2020
| Clinic visit/encounter, all-inclusive | 1,571 | $288,761 |
| Pure tone audiometry (threshold); air only | 327 | $2,165 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 287 | $1,716 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; early childhood (age 1 through 4 years) | 97 | $1,566 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; infant (age younger than 1 year) | 110 | $1,370 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; late childhood (age 5 through 11 years) | 122 | $1,305 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; adolescent (age 12 through 17 years) | 35 | $786 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.25 mL dosage, for intramuscular use | 70 | $397 |
| Pneumococcal conjugate vaccine, 13 valent (PCV13), for intramuscular use | 100 | $387 |
| Diphtheria, tetanus toxoids, acellular pertussis vaccine, Haemophilus influenzae type b, and inactivated poliovirus vaccine, (DTaP-IPV/Hib), for intramuscular use | 22 | $79 |
| Short return visit | 996 | $35 |
| Short return visit (20+ min) | 650 | $24 |
2019
| Clinic visit/encounter, all-inclusive | 1,781 | $229,558 |
| Pure tone audiometry (threshold); air only | 414 | $3,769 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; late childhood (age 5 through 11 years) | 136 | $3,094 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; early childhood (age 1 through 4 years) | 81 | $1,937 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 344 | $1,825 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; adolescent (age 12 through 17 years) | 24 | $484 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; infant (age younger than 1 year) | 44 | $459 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.25 mL dosage, for intramuscular use | 42 | $258 |
| Human Papillomavirus vaccine, types 6, 11, 16, 18, quadrivalent (4vHPV), 3 dose schedule, for intramuscular use | 29 | $129 |
| Pneumococcal conjugate vaccine, 13 valent (PCV13), for intramuscular use | 25 | $89 |
| Short return visit | 524 | $65 |
| Rotavirus vaccine, pentavalent (RV5), 3 dose schedule, live, for oral use | 18 | $50 |
2018
| Clinic visit/encounter, all-inclusive | 1,748 | $185,707 |
| Pure tone audiometry (threshold); air only | 208 | $2,461 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; early childhood (age 1 through 4 years) | 99 | $1,649 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 307 | $1,458 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; late childhood (age 5 through 11 years) | 12 | $532 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, 0.5 mL dosage, for intramuscular use | 102 | $387 |
| Pneumococcal conjugate vaccine, 13 valent (PCV13), for intramuscular use | 37 | $149 |
| Diphtheria, tetanus toxoids, acellular pertussis vaccine, Haemophilus influenzae type b, and inactivated poliovirus vaccine, (DTaP-IPV/Hib), for intramuscular use | 16 | $50 |
| Bilateral quantitative screening test of visual acuity | 31 | $0 |
| Short return visit | 43 | $0 |
| Short return visit (20+ min) | 727 | $0 |
| Return visit (30+ min) | 48 | $0 |
Professional record
- NPI
- 1225198351
- Licence
- CA C53344, MI 4301072758California C53344: Current · expires 2027-12-31
More record details
- Sole proprietor
- No
- Medicaid ID
- MI 4354614
- Taxonomy
- Pediatrics (208000000X)
- Mailing address
- 2030 Forest Ave., Suite 110, Pediatric Center for Life, San Jose, CA, 95128
- NPI first listed
- 2006-12-11
- NPI last updated
- 2011-06-06
This is when the NPI record was last certified, not a medical board exam.